Results All neuropathologies were associated with clinical dementia when controlling for cortical plaques and tangles except Hirano bodies, GVD and brainstem.

Slides:



Advertisements
Similar presentations
Stine N Hansen 1,2, Noreen A Alexander 1,2, Carina von Schantz 3, Outi Kopra 3, Anu Jalanko 3, Jonathan D Cooper 1,2 Neuropathological and reactive changes.
Advertisements

Etiopathogenesis of Alzheimer's disease
Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
Frontotemporal Dementia
MCB 135K: Discussion March 2, General Info Mid-Term I: –Avg 87 –Std. Deviation 10 –Re-grades by next Wednesday Include a cover sheet that addresses.
Aging of the Nervous System: Functional Changes P.S. Timiras.
Aging of the Nervous System: Structural Changes Chapters 7, 8, 9 PS Timiras Chapters 7, 8, 9 PS Timiras.
Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter
CN-1 Neuropathology of Parkinson’s Disease Dementia James B. Leverenz, MD Associate Professor Neurology and Psychiatry and Behavioral Sciences University.
Dementia with Lewy Bodies
Dementia research: knowledge into care Carol Brayne Director Institute of Public Health On behalf of CC75C and CFAS groups.
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
PSYC D Dementias 1 Dementias. Dementias 2 Neurodegenerative Disorders A varied assortment of central nervous system disorders characterized by.
Dr. Omranifard MD 12 may 2015 Depression is one of the most prevalent psychiatric disorders in late life with devastating health consequences. It could.
Alzheimer’s Disease By: Ryan Triplett. Alzheimer’s The deterioration of intellectual capabilities, memory, judgment, and personality to the extent that.
Gender Difference in Alzheimer’s Disease Neuropathology EH Corder, E Ghebremedhin, M Taylor, DR Thal, TG Ohm, H Braak Dr. Senckenbergische Anatomie Department.
Middle and Old Age. Maximum Recorded Life Spans Human Indian Elephant Gorilla Common Toad Domestic Cat Domestic Dog Vampire Bat House Mouse
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part A – AD definition, neuropath? NUCLEAR MEDICINE GRAND.
Chronic disease and its impact on disability and the need for LTC Carol Jagger Experts' Seminar on Ageing and Long-Term Care Needs 20 May 2011.
ALZHEIMER’S PART 2. AD VIDEO
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
Long-term research across the population: looking to the future Fiona Matthews.
Latent Variable Modeling of Neuropathology Data: Implications for Collaborative Science Dan Mungas University of California, Davis Friday Harbor Psychometrics,
ALZHEIMER PATHOLOGY AND NEUROPLASTICITY AD ATTACKS NEUROPLASTIC MECHANISMS NEUROPLASTICITY AS THE FOCUS OF THE ALZHEMIER ATTACK ALZHEIMER ATTACK AS A MODEL.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Cristopher Ramirez Psychology Period 6. A common form of dementia, usually beginning in late middle age, characterize by memory lapses, confusion, emotional.
VIII. NEURODEGENERATIVE DISEASES. - Are disorders characterized by the cellular degeneration of subsets of neurons that typically are related by function,
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 33 Delirium and Dementia.
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
Author : Gyero Reka Coordinator : Prof. Dr. Gabos Grecu Iosif
Care Coordination in the Older Adult with Cancer (CCOAC). C.B Steer 1,, J.P.Donnelly 2,J O’Connor 2. R.J.Myers 2, C.R.Underhill 1, R.W.Eek 1,K. A. Clarke.
Alzheimer’s Disease. Alzheimer's is a the most common form of dementia. Nearly 50-80% of all dementia patients have Alzheimer's. It is a progressive fatal.
Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology Alzheimer’s Disease Avi Gandhi (2009)
Aging Nervous System. Neurotrophic Factors Necessary for Maintenance of Neurons Neurotrophin function o Play role in development of NS o Interact with.
Progressive, degenerative disorder Attacks the brain's neurons Results in loss of memory, thinking and language skills, and behavioral changes Confusion.
Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
The Dementias Dr Giles Richards Consultant Psychiatrist CFT.
Physiological Explanations for Changes in the Brain with Age.
D E M E N T I A Q: What other types of dementia are there? Q: What other types of dementia are there? Q: Do they have the same pathophysiology as Alzeimer.
Epidemiology of Alzheimer’s Disease
Dementia Care Wendy Burnett CNS for Older People.
High resolution MRI at 21.1 T of the hippocampus and temporal lobe white matter in the differential classification of Alzheimer’s Disease & Diffuse Lewy.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Mariano Musacchio 1 François Sellal 2 Frédéric Blanc 2 Jean-Marc Michel 2 Stephan Kremer 3 Jean-Louis Dietemann 3 1 Department of Neuroradiology - CHG.
Apolipoprotein E and Gray Matter Loss in Mild Cognitive Impairment and Alzheimer’s Disease Spampinato MV, Goldsberry G, Mintzer J, Rumboldt Z Medical University.
CPC #7: Pathology Barbara J. Crain, MD, PhD February 25, 2009.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part B – AD and brain systems NUCLEAR MEDICINE GRAND ROUNDS.
The Facts about Dementia and Other Related Conditions Developed by the: University of Wisconsin Oshkosh and Wisconsin Department of Health Services.
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Absence of β-Amyloid Deposits After Immunization in.
Alzheimer Disease Dementia: an acquired, generalized, and often progressive impairment of cognitive function that affects the content, but not the level.
Dementia Jeanette Norden, Ph. D
Dementia with Lewy Bodies
Value of cerebrospinal fluid visinin-like protein-1 (VILIP-1) for prediction of mild cognitive impairment progression to Alzheimer's disease  Mirjana Babić.
The ageing brain Volume reduction: begins around 50 with a loss of brain weight of around 2-3% per decade Changes in nerve cell numbers and size - various.
Copyright © 1999 American Medical Association. All rights reserved.
DOI: /j.neurobiolaging
Is the freedom from Cognitive Impairment really at hand?
Changing demographics and the impact on dementia
Alzheimer Disease Dementia: an acquired, generalized, and often progressive impairment of cognitive function that affects the content, but not the level.
Alzheimer Disease Dementia: an acquired, generalized, and often progressive impairment of cognitive function that affects the content, but not the level.
65 year-old female with Alzheimer’s disease
Chapter 30 Delirium and Dementia
Volume 15, Issue 13, Pages (December 2016)
[18F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β.
Katharine James Clinical Neurosciences Research Unit
Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease  W. Robert Bell, Yang An,
Presentation transcript:

Results All neuropathologies were associated with clinical dementia when controlling for cortical plaques and tangles except Hirano bodies, GVD and brainstem plaques. These included: hippocampal and entorhinal gliosis; cortical, hippocampal and entorhinal neuronal loss, along with brainstem neuronal loss, gliosis, pigmentary incontinence, Lewy bodies and tangles. See Figure 2. Pick bodies were present in five individuals, all had clinical dementia. Less common and “disregarded” pathologies in late onset dementia: what are we missing? Hannah A.D. Keage 1,2, Paul G. Ince 3, Fiona E. Matthews 4, Stephen B Wharton 3, Ian McKeith 5 and Carol Brayne 2 1 Cognitive Neuroscience Laboratory, School of Psychology and Social Work, University of South Australia, Australia; 2 Department of Public Health and Primary Care, University of Cambridge, UK; 3 School of Medical and Biomedical Sciences, University of Sheffield, UK; 4 MRC Biostatistics Unit, Cambridge, UK; 5 Newcastle Biomedicine, University of Newcastle, UK Contact Dr Hannah Keage Supported by a Marie Curie International Incoming Fellowship and an Australian NHMRC Training Fellowship Background o The pathological basis of late onset dementia is typically conceptualised in terms of cortical amyloid, tau and vascular pathologies. o The significance of less common pathologies associated with dementias such as Pick bodies, cortical atrophy and subcortical tau to dementia in the old is unknown. o The independent contributions of neuropathologies generally accepted to be common in dementia such as Hirano bodies, gliosis, granulovacuolar degeneration (GVD) are also unknown. o The current study investigated the relationship between these less common and “disregarded” neuropathologies to late onset dementia in a population-based sample of older people. Method o The sample was drawn from the Epidemiological CLInicoPathological Studies in Europe (EClipSE) project ( which is a harmonisation of population-based autopsy and clinical data (in this case, the MRC Cognitive Function and Ageing Study and the City of Cambridge over-75 Cohort). o 627 individuals aged years, 55% clinically demented at death. o Pathologies assessed included: Pick bodies, severe neuronal loss, gliosis and GVD in the cortex and/or hippocampus, as well as brainstem plaques, tangles, severe neuronal loss, gliosis, pigmentary incontinence and Lewy bodies. See Figure 1 for selected examples. o Brainstem regions included: substantia nigra, nucleus basalis, raphe nucleus, locus coeruleus and vagas nerve. o Associations between each pathological marker and clinical dementia were assessed, taking into account cortical plaques and tangles. Key points o The underlying neuropathological basis of late onset dementia is complex. o The brainstem may play a more critical role than previously recognised. Conclusion Findings contribute to the emerging understanding that late onset dementia is associated with a broad range of neuropathologies and anatomical regions. Gliosis and neuronal loss appear to play independent roles (when taking into account classic makers), as do a variety of pathologies within the brainstem. The population-based approach gives extra weight to results as individuals were sourced from, and the sample is representative of, the general population rather than people referred to clinics or brain banks. Future work should include these less common and “disregarded” pathologies and anatomical regions. Figure 1. Left – The CA1 region of the hippocampus showing a Hirano body (open arrow) and granulovacuolar degeneration in 2 neurons. Scale bar 0.05mm. Middle – entorhinal cortex showing neuronal loss and superficial gliosis. Scale bar 0.5mm. Right – atrophic cerebral cortex showing neuronal loss and gliosis in a case showing Frontotemporal dementia ubiquitin positive pathology. Scale bar 1mm. Figure 2. Associations (odds ratios and 95% confidence internals) between cortical, hippocampal and entorhinal, and brainstem pathologies and clinical dementia status at death. Model 1/M1adjusted for age group, study and sex Model 2/M2adjusted for age group, study, sex, cortical neuritic plaques and Braak stage Risk of clinical dementia: cortical, hippocampal and entorhinal pathologies Risk of clinical dementia: brainstem pathologies Odds ratio Key Ent.cotex – entorhinal cortex Hip. – hippocampus Pig.incontinence - pigmentary incontinence GVD – granulovacuolar degeneration Hirano – Hirano bodies